Cenduit Selects SAP BusinessObjects Edge Solutions to Revolutionize Clinical Trial Reporting and Analytics

SAP NEWSBYTE - December 09, 2009 - Cenduit, LLC, a joint venture of industry powerhouses Quintiles and Thermo Fisher Scientific, recently selected SAP BusinessObjects™ Edge solutions to enhance custom reporting and analytics capabilities within its Interactive Response Technology (IRT) solutions.

Cenduit's IRT solution is instrumental in collecting, analyzing and managing clinical trial data. Cenduit's clients — pharmaceutical, clinical research and biotechnology organizations — rely on IRT solutions to effectively manage randomization and drug supply management of their clinical studies. The SAP BusinessObjects software includes visually compelling, ad-hoc reports and digital dashboards through which Cenduit takes the business efficiencies of its proven IRT solution to the next level.

"We carefully chose the SAP BusinessObjects Edge reporting and analytics solution since it is simply the best in class solution for analytics and reporting available today," said Dr. Jogin Desai, chief executive officer, Cenduit. "Real-time information on patient recruitment and drug supply management will enable our project managers to proactively advise clients and partners on business decisions to improve study productivity and dramatically reduce clinical trial costs."

Business intelligence gleaned from trends in programs over time will help clinical trial personnel devise meaningful strategies for running cost-efficient clinical trials. Together, Cenduit and SAP provide best-in-class clinical trial solutions that focus on transforming data-driven decision-making throughout the drug supply chain management and drug development process to achieve substantial study efficiencies and cost savings.